日本生理学会大会発表要旨集
日本生理学会大会発表要旨集
セッションID: 1PHP-028
会議情報
血管異常収縮の原因分子、スフィンゴシルホスホリルコリンの血清濃度測定法の開発
*高田 雄一岸 博子川道 穂津美加治屋 勝子郭 鳳玲徐 丹王 晨松尾 さやか三輪 さおり小林 誠
著者情報
会議録・要旨集 フリー

詳細
抄録
Recently we have reported that sphingosylphosphorylcholine (SPC), which is a sphingolipid mediator and generated by N-deacylation of sphingomyelin, causes Rho-kinase-mediated Ca2+-sensitization of vascular smooth muscle, thereby leading to abnormal vascular contraction, such as cerebral vasospasm after subarachnoid hemorrhage (SAH). Indeed, SPC concentration in cerebrospinal fluid is much higher in post-SAH patients than in non-SAH patients. In addition, various vascular diseases, such as acute cerebral and myocardial infarction, are also likely to involve the vasospastic activity. Therefore, in order to assess the relationship between SPC concentration and vascular diseases, we tried to develop a rapid and accurate method to measure the serum concentration, using a reversed phase high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry (HPLC/ESI-MS/MS). Using deuterium-labeled SPC as an internal standard, the ratio of ion abundance was determined by multiple reaction monitoring mode. The optimized HPLC/ESI-MS/MS condition was sufficient for the construction of linear calibration curve and continuous analysis. Furthermore, we examined the influence of differences in the technical procedures for the blood collection and the sample preparation and measurement on the yield and stability of SPC. [J Physiol Sci. 2007;57 Suppl:S125]
著者関連情報
© 2007 日本生理学会
前の記事 次の記事
feedback
Top